Juhani Kivijärvi

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

Mehiläinen Oy provides healthcare and social care services. It offers physician services, diagnostics, surgeries, dental and emergency care, as well as home and residential care services for the elderly and disabled, mental health rehabilitation, and child welfare services. The company serves private, insurance, corporate, and municipal customers. Mehiläinen was founded by Reguel Lofqvist, Akseli Koskimies, Walter Sipila, and K. F. Hirvisalo on November 6, 1909 and is headquartered in Helsinki, Finland.

Mercurio OÜ develops and manufactures respiratory disorder medical devices. Its products include devices, accessories, tubes, humidifiers, and masks. The company was founded on June 13, 2011 and is headquartered in Tallinn, Estonia.

Cint AB operates as a software company that develops technology. The firm specializes in software as a service solutions, as well as panel management products. Its OpinionHUB, is an exchange platform linking buyers, suppliers, and resellers of online sample. The company was founded by Bo Lennart Mattsson in 1998 and is headquartered in Stockholm, Sweden.

Telenor Connexion AB provides machine-to-machine communications services. It offers IoT solutions, IoT design and project management, and managed IoT cloud. The company is headquartered in Stockholm, Sweden.

Nasdaq Technology AB develops information technology systems for order generation, trading operations, clearing operations, back office administration, and related activities. The company is headquartered in Stockholm, Sweden.

Part of Johnson & Johnson, Johnson & Johnson Nordic AB develops, manufactures, and sells personal care hygienic products, pharmaceuticals, and surgical equipment. The company is based in Sollentuna, Sweden.

Part of AstraZeneca PLC, Cambridge Antibody Technology Group Ltd. is a holding company that oversees its subsidiaries' research, development, and exploitation of molecular engineering products. The company is based in Cambridge, UK and was founded in 1996.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany.

MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.

Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA.

Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway.

7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark.

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom.

Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX.

AWA Holding AB is a full-service intellectual property law firm that specializes in managing licensing deals and ensuring optimum protection through robust contracts and clauses. The private company is based in Malmö, Sweden, and has subsidiaries in Denmark. The Swedish company's experienced professionals help clients capture the true value of their intellectual property rights during any licensing activity or other IP transactions. The company offers services in patents, trademarks, design, copyright, and domain names. AWA has over 4,300 clients who trust them as their intellectual property partner. The company also provides a tool to evaluate patent costs for the European patent system compared to the unitary patent system.